A randomised phase III study of bevacizumab and carboplatin–pemetrexed chemotherapy with or without atezolizumab as first-line treatment for advanced pleural mesothelioma: results of the ETOP 13-18 BEAT-meso trial

Enriqueta Felip, Sanjay Popat, Urania Dafni, Karin Ribi, A. Pope, S. Cedres, R. Shah, F. de Marinis, Laura Cove Smith, R. Bernabé, Martin Früh, K. Nackaerts, Laurent Greillier, Amina Scherz, B. Massutí, Ernest Nadal, L. Vila Martinez, Thomas Talbot, Heidi Roschitzki‐Voser, Georgia Dimopoulou, S Schär, Barbara Ruepp, Sinisa Savic, Solange Peters, Rolf A. Stahel